Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - G
Gene Medicine Japan Inc. Japanese based company committed to research and develop innovative gene medicine technologies such as adenoviral vectors and cell processing. |
|
Genemedi Biotechnology company with long standing expertise in AAV production, AAV vector optimizion, capsid evolution and new AAV generation. |
|
GenePharma Shanghai The company has internationally lead siRNA chemical synthesis complete core technology, including RNA monomer synthesis technology, common and chemically modified siRNA oligo synthesis technology. |
|
Genlantis Commercial firm focused on developing reagents for transfection, gene expression, gene Silencing, RNA interference, primary cell culture, and sample preparation in proteomics research. |
|
Genomics, Inc. Shanghai Company's mission is to develop novel therapeutic products for diseases prevalent in Asia, especially in the areas of lung fibrosis, liver fibrosis, cancer, and new biomaterials for bone healing. Shanghai Genomics also provides drug registration services and operates as a clinical research organization (CRO). | |
George Clinical George Clinical is a leading clinical contract research organisation company in Asia with over 260 global staff. George Clinical provides the full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability to create a distinctive world-class service CRO. |
|
GenVec, Inc. Biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Lead product TNFerade™ is used in locally advanced pancreatic cancer, rectal cancer, melanoma, and head and neck cancer. GenVec uses adenovector technology to develop vaccines for infectious diseases. |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Robots and AI: The Future of Cell and Gene Therapy Manufacturing - Genetic Engineering & Biotechnology News
Wed, 27 Mar 2024 17:00:2 GMT - Gene therapy offers hope for giant axonal neuropathy patients - UT Southwestern
Wed, 27 Mar 2024 16:52:2 GMT - Gene Therapy, DNA's Past, RNA's Future: Early History - Forbes
Wed, 27 Mar 2024 16:20:5 GMT - Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint - BioSpace
Wed, 27 Mar 2024 16:18:4 GMT - Atamyo's gene therapy for LGMD2C/R5 cleared to enter clinic in Europe - BioWorld Online
Wed, 27 Mar 2024 14:00:0 GMT - Intellia ending work with Regeneron on hemophilia B gene therapy - Hemophilia News Today
Wed, 27 Mar 2024 13:35:0 GMT - Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe - Clinical Trials Arena
Wed, 27 Mar 2024 12:26:4 GMT - Competitive Intelligence Insights: Cell & Gene Therapy - Evaluate Pharma
Wed, 27 Mar 2024 11:55:4 GMT - Gene therapy maker bluebird to revise financials after accounting errors - Reuters
Tue, 26 Mar 2024 15:55:0 GMT - Why Alzheimer's Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence - Medpage Today
Tue, 26 Mar 2024 15:17:1 GMT - Maryland non-profit sets up gene therapy production in Brazil - FiercePharma
Tue, 26 Mar 2024 13:44:2 GMT - Gene therapy maker bluebird to restate financials after accounting errors - Investing.com
Tue, 26 Mar 2024 13:33:4 GMT - Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in ... - Yahoo Finance
Tue, 26 Mar 2024 13:00:0 GMT - Nanoscope preps filing for retinitis pigmentosa gene therapy - pharmaphorum
Tue, 26 Mar 2024 12:11:3 GMT - Intrathecal Gene Therapy Shows Promise in Giant Axonal Neuropathy - Physician's Weekly
Tue, 26 Mar 2024 08:18:4 GMT